The Peter Attia Drive

The Peter Attia Drive

#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins

Nov 13, 2023 · 27:10

Listen to Episode

✨ AI Summary

Examines metabolic drugs like SGLT-2 inhibitors and GLP-1 agonists.
Assesses geroprotective potential of SGLT2 inhibitors.
Analyzes statin use and insulin resistance risk.

More from The Peter Attia Drive

#385 - AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more

Mar 23, 2026 · 18:52

#384 - Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention

Mar 16, 2026 · 52:40

#381 ‒ Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.

Jan 26, 2026 · 02:06:34

#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.

Jan 19, 2026 · 02:07:42

View all episodes →